South China Children Cancer Group - Relapsed-Acute Lymphoblastic Leukemia 2022 Protocol | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
South China Children Cancer Group - Relapsed-Acute Lymphoblastic Leukemia 2022 Protocol	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm	Recruiting	Phase 4	2023-01-12		NCT05682131

14 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
First Affiliated Hospital of Guangxi Medical University	96
First Affiliated Hospital of Shantou University Medical College	8
First Affiliated Hospital, Sun Yat-Sen University	113
Guangzhou First People's Hospital	32
Hainan People's Hospital	12
Huizhou Municipal Central Hospital	21
LiuZhou People's Hospital	15
Second Xiangya Hospital of Central South University	95
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	285
The First Affiliated Hospital of Guangzhou Medical University	95
Third Affiliated Hospital, Sun Yat-Sen University	64
Zhongshan Bo Ai Hospital	1
Zhongshan People's Hospital, Guangdong, China	46
Zhujiang Hospital	82

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Sun Yat-sen Memorial Hospital, Sun Yat-sen University	Guangzhou	China	67